UNIIED Sums PA'IENT AND Tmuamm Ol—HCE
`
`
`
`UNITED FIT-“T‘s DI‘TP-I. IITMI‘NT HI" COMMI‘IRF‘I‘"
`United Sunni-A Patent and Trademark lli‘l‘im
`.-'u'leh 1"I "J]\'|\-' ISSIUMFR F'"IR PATEI-"Th'r
`PL Ei-rxl' in)
`AL amtdri'u. quunm 1" 3|i- l-I'FIJ
`wwwl..‘|1Ii1 gm
`
`J\l7'17'I.II.'.'J\TII')N
`FILING rn‘
`("IRP ARI'
`
`NUMBEd
`3'? [It] DATE
`I'NIT
`I"I]. FEE. REC" D
`\_-TT‘i' DOCKET. NO
`T‘OT CLAIMS IND CLAIMS-
`61915.1[3
`1312:9013
`41188- "1'20. 10]
`
`21971
`WILSON. SONSINI, GOODRICH & ROSATI
`65o FAGE MILL ROAD
`PALO ALTO. CA 94304—1050
`
`CONFIRMATION NO. 4839
`
`FILING RECEIPT
`
`|IIIIIIIIIIIIIIIHIMIQIQIMIMIIIIIIMIIIIIIlIIIIIIIIII
`
`Date Mailed: 12f24r’2013
`
`It will not be examined for patentability and will
`Fieceipt is acknowledged of this provisional patent application.
`become abandoned not later than twelve months after its filing date. Any correspondence concerning the application
`must include the following identification information: the U.S. APPLICATION NUMBER, FILING DATE, NAME OF
`APPLICANT. and TITLE OF INVENTION. Fees transmitted by check or draft are subject to collection. Please verify
`the accuracy of the data presented on this receipt. I! an error is noted on this Filing Receipt, please submit
`a written request for a Filing Receipt Correction. Please provide a copy of this Filing Receipt with the
`changes noted thereon. If you received a "Notice to File Missing Parts" for this application, please submit
`any corrections to this Filing Receipt with your reply to the Notice. When the USPTO processes the reply
`to the Notice, the USPTO will generate another Filing Receipt incorporating the requested corrections
`
`lnventor(s)
`
`Euan THOMSON. San Francisco. CA;
`
`Nupur SRIVASTAVA. San Francisco. CA:
`Omar DAWOOD, San Francisco, CA;
`lman ABUZEID. San Francisco. CA. CANADA;
`
`Applicant(s)
`
`AliveCOR. Inc, San Francisco. CA
`
`Power of Attorney:
`Darby Chan—62407
`
`Permission to Access - A proper Authorization to Permit Access to Application by Participating Ofiices
`(PTOJSBJ39 or its equivalent) has been received by the USPTO.
`
`It Required, Foreign Filing License Granted: 12r17r2013
`
`The country code and number of your priority application, to be used for filing abroad under the Paris Convention.
`is US 61/915,113
`
`Projected Publication Date: None. application is not eligible Ior pre-grant publication
`
`Non-Publication Request: No
`
`Early Publication Request: No
`** SMALL ENTITY **
`Title
`
`METHODS AND SYSTEMS FOR ARHHYTHMIA TRACKING AND SCOHENG
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition Applications: No
`page 1 of3
`
`APPLE 1026
`
`APPLE 1026
`
`1
`
`

`

`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a US. patent extend only throughout the territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the same invention in member countries. but does not result in a grant of "an international
`patent" and does not eliminate the need of applicants to file additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordance with its particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely.
`
`Applicants also are advised that in the case of inventions made in the United States, the Director of the USPTO must
`issue a license before applicants can apply fora patent in a foreign country. The filing of a U.S. patent application
`serves as a request for a foreign filing license. The application's filing receipt contains further information and
`guidance as to the status of applicant's license for foreign filing.
`
`Applicants may wish to consult the USPTO booklet, "General Information Concerning Patents" (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timefran'les and deadlines for filing foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 809786—9199. or it
`can be viewed on the USPTO website at httpzftwwwuspto.govfwebtofficesi'pactdoctgeneraltindexhtml.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the US. Government website, httpflwwwstopfakesgov. Part of a Department of Commerce initiative.
`this website includes self-help "toolkits" giving innovators guidance on how to protect intellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcement issues. applicants may
`call the US. Government hotline at I-BBS-QQQ-HALT (1-856-999-4258).
`
`LICENSE FOFt FOREIGN FILING UNDEFt
`
`Title 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 8: 5.15
`
`GRANTED
`
`The applicant has been granted a license under 35 U.S.C. 184. if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or not a license may be required as
`set forth in 37 CFR 5.15. The scope and limitations of this license are set forth in 37 CFR 5.15(a) unless an earlier
`license has been issued under 37 CFH 5.15(b). The license is subject to revocation upon written notification. The
`date indicated is the effective date of the license, unless an earlier license of similar scope has been granted under
`37 CFR 5.13 or 5.14.
`
`page 2 of 3
`
`2
`
`

`

`This license is to be retained by the licensee and may be used many time on matter the effective date thereof unless
`it is revoked. This license is automatically transferred to any related applications(s) filed under 37 CFR 1.53td). This
`license is not retroactive.
`
`The grant of a license does not in any way lessen the responsibility of a licensee for the security of the subject matter
`as imposed by any Government contract or the provisions of existing laws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselves of current regulations especially with
`respect to certain countries, of other agencies. particularly the Office of Defense Trade Controls. Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121—128)); the Bureau of Industry and
`Security, Department of Commerce (15 CFR parts 730—774); the Office of Foreign AssetsControl, Department of
`Treasury (31 CFR Parts 500+) and the Department of Energy.
`
`W N
`
`o license under 35 U.S.C. 184 has been granted at this time, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" DOES NOT appear on this form. Applicant may still petition for a license under 37 CFR 5.12.
`if a license is desired before the expiration of 6 months from the filing date of the application. If 6 months has lapsed
`from the filing date of this application and the licensee has not received any indication of a secrecy order under 35
`U.S.C. 181. the licensee may foreign file the application pursuant to 37 CFR 5.15(b).
`
`
`
`SelectUSA
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for
`business investment, innovation. and commercialization of new technologies. The US. offers tremendous resources
`and advantages for those who invest and manufacture goods here. Through SelectUSA, ow nation Works to
`promote and facilitate business investment. SelectUSA provides information assistance to the international investor
`community; serves as an ombudsman for existing and potential investors; advocates on behalf of US. cities, states.
`and regions competing for global investment; and counsels US. economic development organizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology. manufacture products, deliver services. and grow your business, visit httpigrwwwSelectUSAgov or call
`+1—202—482—6800.
`
`page 3 of 3
`
`3
`
`

`

`PTOISBHE (03-13)
`Approved for use through 01i31i2l314. OMB 0651—0032
`U.S. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of inionl’lalion unless it displays a yalitl OMB control number
`
`PROVISIONAL APPLICATION FOR PATENT COVER SHEET — Page 1 of 2
`This is a request for filing a PROVISIONAL APPLICATION FOR PATENT under 37 CFR 1.531c}.
`Express Mail Label No. NIA
`
`Gwen Name-[first and middle [If anyll
`
`lNVENTOR(S)
`
`Family Name or Surname
`
`Residence
`{City and either State or Foreign Country)
`
`THOMSON
`
`SRIVASTAVA
`
`DAWOOD
`
`ABUZEID
`
`San Francisco, CA
`
`San Francisco, CA
`
`San Francisco‘ CA
`
`San Francisco. CA
`
`Additional inventors are being named on the
`
`separately numbered sheets attached hereto
`
`TITLE OF THE INVENTION [500 characters max}:
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`
`
`
`Direct all correspondence to:
`
`CORRESPONDENCE ADDRESS
`
`E The address corresponding to customer Number:
`on
`
`0219?1
`
`I Firm or
`individual Name
`Address
`
`aw
`
`Country
`
`Telephone
`
`2m
`
`ENCLOSED APPLICATION PARTS (check all that apply)
`Application Data Sheet. See 3? CFFI 1.?6
`‘3 {Dis}. Number of CDs
`?
`E Drawingls} Number of Sheers
`D Other {specify}
`Specification leg. description of the.l invention} Number of Pages
`1.5
`
`Fees Due: Filing Fee of $260 [$130 for small entity} [$65 for micro entity]. if the specification and drawings exceed 100 sheets of paper, an
`application size fee is also due, which is $400 [$200 for small entity] {$100 for micro entity} for each additional 50 sheets or fraction thereof.
`See 35 u.s.c. 41(al(1](G] and 37 cm 1.16Is].
`METHOD OF PAYMENT OF THE FILING FEE AND APPLICATION SIZE FEE FOR THIS PROVISIONAL APPLICATION FOR PATENT
`v
`
`Applicant claims small entity status.5ee 3? CFR 1.2T.
`
`I:I Applicant certifies microentitystatus. See3? cm 1.29.
`Applicant must attach form PTOiSBiifiA or B or equivalent.
`D A check or money order made payable to the Director of the United States Patent
`and Trademark Ofi’ice is enclosed to cover the filing lee and application size fee [if applicable}.
`
`m
`TOTAL FEE AMOUNT {5}
`
`|:| Payment by credit card. Form PTO-2033 is attached
`E The Director is hereby authorized to charge the filing fee and application size fee (if applica blel or credit any overpayment to Deposit
`Account Number: 23—2415.
`
`USE ONLY FOR FILING A PROVISIONAL APPLICATION FOR PATENT
`This collection of information is required by 3? CFR 151. The Information is required to obtain or retain a benefit by the public which is to file iancl by the USPTD to
`process] an application. Con ildenliallty is governed by 35 U.S.C. 122 and 3? CFR 1,11 and 1.14. This collection Is estimated to take 10 hours to complete, including
`gathering. preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case Any comments on the
`amount of time you require to complete this form andfor suggestions for reducing this burden. should be sent to the I'Jlief lniormatlon Officer_ LLS. Patent and
`Trademark Office, US Department of Com merce, PO Box 1450. Alexandria. VA 22313—1431 DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND
`TO: Commissionerfor Patents. ED. Box “50, Alexandria, VA 22313-1050.
`lfyou need assistance in completing the form, coil 1—8t10—PTO-9199 ondseiect oprion 2.
`
`59700914.ch
`
`4
`
`4
`
`

`

`PTOlSB/16 (03-13)
`Approved for use through D1i'31i'2014. OMB 0651-0032
`U_S. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1 995. no persons are required to reapond to a collection oi information unless it displays a valid OMB control number.
`
`PROVISIONAL APPLICATION FOR PATENT COVER SHEET — Page 2 of 2
`
`The invention was made by an agency ofthe United States Government or under a contract with an agency of the United States Government.
`
`Government contract num her are:
`
`ENo
`I] Yes, the invention was made by an agencv of the U.S. Government. The U.5_ Government agency name is:
`
`
`
`
`D Yes, the invention was made under a contract with an agency of the LLS. Government. The name of the US. Government agency and
`
`WARNING:
`
`Petitionerfapplicant is cautioned to avoid submitting personal information in documents filed in a patent application that may
`contribute to identity theft. Personal iniormation such as social security numbers, bank account numbers, or credit card
`numbers {other than a check or credit card authorization form PTO—2038 submitted for payment purposes] is never required by
`the USPTO to support a petition or an application. If this type of personal information is included in documents submitted to
`the USPTD, petitionersi’applicants should consider redacting such personal information from the documents before submitting
`them to the USPTO. Petitionerfapplicant is advised that the record ofa patent application is available to the public after
`publication ofthe application [unless a non-publication request in compliance with 37 CFR 1.213lal is made in the applicationl
`or issuance of a patent. Furthermore, the record from an abandoned application may also be available to the public if the
`application is referenced in a published application or an issued patent {See 37 CFR 1.14]. Checks and credit card authorization
`forms PTO-2038 submitted for payment purposes are not retained in the application file and therefore are not publicly
`available.
`
`SIGNATURE
`
`
`i‘Darlgy J. Chan}r
`Date December 12, 2013
`
`TYPE) or PRINTED NAME
`
`Darby J. Chan
`
`REGISTRATION no.
`(ifoppropriote)
`
`62,407
`
`TELEPHONE 650.493.9300
`
`Docket Number: 41 WES—720.101
`
`5970091__1.doc
`
`5
`
`

`

`PTOIAIN14 (03-13)
`Approved for use through 0113112014. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`_
`
`_
`
`document may be printed and included in a paper filed application.
`
`Title of Invention
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`Secrecy Order 37 CFR 5.2
`
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`
`
`Inventor Information:
`
`
`
`Legal Name
`
`
`
`Inventor
`
`
`
`1
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`
`30 Maiden Ln.
`
`
`Address 2
`
`City
`
`San Francisco
`
`StatelProvince
`
`i CA
`
`
`Inventor
`2
`
`Legal Name
`
`
`Nupur
`SRIVASTAVA
`
`Residence Information (Select One)
`
`(9 US Residency 0 Non US Residency 0 Active US Military Service
`
`Mailing Address of Inventor:
`
`
`Address 1
`30 Maiden Ln.
`
`m
`3
`Inventor
`
`Legal Name
`
`Prefix Given Name
`Middle Name
`Family Name
`—— eweee
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`
`Suffix
`-
`
`EFS Web 2.2.8
`
`6
`
`
`Prefix Given Name
`Middle Name
`
`Family Name
`
`
`
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`
`StateI'Province
`
`Country of Residencei
`
`US
`
`
`
`
`
`
`6
`
`

`

`PTOIAIN14 (03-13)
`Approved for use through 01/3112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`-
`
`Appllcatlon Data Sheet 37 CFR 1.76
`
`-
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`
`
`
`
`San FranciscoCity | Country of Residenceii US ‘ StatelProvince | CA
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`Inventor
`
`4
`
`Legal Name
`
`Prefix Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`
`
`Residence Information (Select One)
`
`(9 US Residency 0 Non US Residency 0 Active US Military Service
`
`City
`
`San Francisco
`
`StatelProvince
`
`CA
`
`Country of Residence i
`
`CA
`
`
`
`Mailing Address of Inventor:
`
`30 Maiden Ln.
`
`Address 1
`
`
`Address 2
`
`
`
`
`
`
`
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`generated within this form by selecting the Add button.
`
`
`
`
`
`
`
`
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`|:| An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`21971
`
`
`
`
`Email Address
`|
`Add Email
`
`Application Information:
`
` METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of the Invention
`
`
`
`Attorney Docket Number
`Small Entity Status Claimed
`
`
`
`
`
`Application Type
`
`
`
`Subject Matter
`
`Total Number of Drawing Sheets (if any) _—
`
`
`EFS Web 2.2.8
`
`7
`
`7
`
`

`

`PTOIAIN14 (03-13)
`Approved for use through 01/3112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`_
`
`
`
`41188-720101
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`
`Publication Information:
`
`
`|:| Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`El
`
`Request Not to PUinSh. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`
`Customer Number
`
`21971
`
`@ Customer Number
`
`0 us Patent Practitioner 0 Limited Recognition (37 CFR11.9)
`
`Domestic Benefit/National Stage Information:
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Foreign Priority Information:
`
`
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55(d). When priority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX) ithe information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(h)(1) and (2). Under the PBX program, applicant bears the ultimate
`
`
`
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g)(1).
`
`
`
`
`Filing Date (YYYY-MM-DD)
`
`Country i
`Access Codei (if applicable)
`Application Number
`
`
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`
`
`EFS Web 2.2.8
`
`8
`
`
`
`8
`
`

`

`PTOIAIN14 (03-13)
`Approved for use through 01/3172014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`-
`
`Appllcatlon Data Sheet 37 CFR 1.76
`
`-
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`|:| 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`
`16, 2013, will be examined under the first inventor to file provisions of the AIA.
`
`Authorization to Permit Access:
`
`Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 114(0) and (h). This box should not be checked if the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as—filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)—(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any US. application-as—filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date of filing this Authorization.
`
`
`
`
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`
`to have an assignment recorded by the Office.
`
`EFS Web 2.2.8
`
`9
`
`9
`
`

`

`PTOIAIN14 (03-13)
`Approved for use through 01/3112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`-
`
`Application Data Sheet 37 CFR 1.76—
`
`-
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`Applicant
`
`1
`
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`@ Assignee
`
`0 Legal Representative under 35 U.S.C. 117
`
`0 Person to whom the inventor is obligated to assign.
`
`0 Person who shows sufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Email Address
`
` 0 Joint Inventor
`
`Name of the Deceased or Legally lncapacitated Inventor::|
`If the Applicant is an Organization check here.
`
`Mailing Address Information:
`
`Address 1
`
`Address 2
`
`City
`
`Country i US
`
`30 Maiden Ln.
`
`San Francisco
`
`StatelProvince
`
`CA
`
`Postal Code
`
`94108
`
`
`
`Additional Applicant Data may be generated within this form by selecting the Add button. Add
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an assignment recorded by the Office.
`
`
`
`Assignee
`
`1
`
`Complete this section if assignee information, including non—applicant assignee information, is desired to be included on the patent
`application publication . An assignee-applicant identified in the "Applicant Information" section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assignee is also desired on the
`patent application publication.
`
`Remove
`
`If the Assignee is an Organization check here.
`
`|:|
`
`EFS Web 2.2.8
`
`10
`
`
`
`10
`
`

`

`PTOIAIN14 (03-13)
`Approved for use through 01/3112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`-
`
`Appllcatlon Data Sheet 37 CFR 1.76
`
`-
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`
`
`
`
`Mailing Address Information:
`
`Address 1
`‘
`
`Address 2
`
`City—’7 StatelProvince
`
`
`Additional Assignee Data may be generated within this form by selecting the Add button.
`
`Signature:
`
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`
`
`
`
`
`Signature
`
`lDarbyJ.Chan/
`
`Date (YYYY-MM-DD)
`
`2013-12-12
`
`
`
`First Name
`
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, US Patent and
`Trademark Office, US. Department of Commerce, PO. Box 1450, Alexandria, VA 22313—1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.8
`
`1 1
`
`11
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the US. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the US. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency havmg need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 131) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuan
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`
`
`9.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.8
`
`12
`
`

`

`ABSTRACT OF THE DISCLOSURE
`
`A dashboard centered around arrhythmia or A-fib tracking is provided. The dashboard
`
`includes a heart or cardiac health score that can be calculated in response to data from the user such
`
`as their ECG and other personal information and cardiac health influencing factors. The dashboard
`
`also provides to the user recommendations or goals. such as daily goals, for the user to meet and
`
`thereby improve their heart or cardiac health score. These go